Rapid Science is a non-profit organization that strives to accelerate scientific discovery by offering open and collaborative networking tools. The company is betting that custom tools, expert facilitation and realigned incentives will result in authentic collaboration and more reliable and valuable outcomes. To this end, the company created an online Collaboration Portal where the act of publishing is incidental to the search for faster, better cures.
In the fall of 2016, Rapid Science asked Six Feet Up for help with the development of the second iteration of their Rapid Science Collaboration Portal: Sarcoma Central.
When Rapid Science came to Six Feet Up, they were running two separate Django-based web applications (“Rapid Science Collaboration Portal” and “Cases Central”) to power their online efforts.
Since we were brought in on an existing system, we had to first get acquainted with the legacy code and existing specs. As is usual in first software development iterations, accurate documentation was lacking in both areas. The list of desired improvements was also very long, unorganized and lacking details.
After an initial Blueprint Exploratory phase, the following priorities emerged:
As part of the merge, the apps had to be upgraded to the latest version of Django and Solr had to be reconfigured to be the default search function.
A Living SpecBook was put together to document and organize the designed improvements. All the features were documented in tickets that were organized by component, milestones and priorities. Tasks were associated with testable business requirements. Diagrams were developed to explain and illustrate complex permission workflows. Smoketests were developed for quality assurance.
We moved forward in an Agile way, working on top priorities first, with ongoing back and forth communications with Rapid Science and their designer.
The site is served from one of Six Feet Up's private cloud VMs.
The first pilot community, Sarcoma Central, provides clinical researchers and other healthcare professionals with an online venue where to discuss outcomes of clinical trials and insights from their own practices. Online members use the platform to better understand the biology and efficacy of experimental and approved therapies.
Participants can:
Sarcoma Central has received strong interest from large scientific communities, international pharmaceutical groups, as well as government entities. This has been a highly gratifying project for the Sixies to work on due to the project's potential impact on the global healthcare system as well as human lives.